Cargando…
Rapamycin reduces kidney volume and delays the loss of renal function in a patient with autosomal-dominant polycystic kidney disease
This is the first report of a case of a reduction in kidney volume and preservation of renal function in a patient with autosomal-dominant polycystic kidney disease (ADPKD) receiving rapamycin. A 42-year-old man with ADPKD and a severe persistent bleeding from his solitary left kidney was successful...
Autores principales: | Peces, Ramón, Peces, Carlos, Pérez-Dueñas, Virginia, Cuesta-López, Emilio, Azorín, Sebastián, Selgas, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421355/ https://www.ncbi.nlm.nih.gov/pubmed/25949309 http://dx.doi.org/10.1093/ndtplus/sfn210 |
Ejemplares similares
-
Nephrotic Syndrome and Idiopathic Membranous Nephropathy Associated with Autosomal-Dominant Polycystic Kidney Disease
por: Peces, Ramón, et al.
Publicado: (2011) -
Bilineal inheritance of type 1 autosomal dominant polycystic kidney disease (ADPKD) and recurrent fetal loss
por: Peces, Ramón, et al.
Publicado: (2008) -
Sacral radicular cysts in autosomal dominant polycystic kidney disease
por: Peces, Ramón, et al.
Publicado: (2009) -
Birth of two healthy girls following preimplantation genetic diagnosis and gestational surrogacy in a rapidly progressive autosomal dominant polycystic kidney disease case using tolvaptan
por: Peces, Ramón, et al.
Publicado: (2021) -
Co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2
por: Peces, Ramón, et al.
Publicado: (2020)